180 Fenglin Road
Shanghai, 200032, China
Location status: Recruiting
NCT Number: NCT06253962
Carotid plaque burden and composition features, particularly lipid necrotic core, are significantly associated with severity of CAD stenosis. This study aims to explore the relationship between various phenotypic patterns of carotid atherosclerosis with the prevalence, phenotype, and severity of coronary atherosclerosis. The patients with chest tightness or chest pain will receive carotid artery ultrasonography before coronary angiography so as to explore the relationship between them.
Interested in participating?
Request Info14 year–90 year
All sexes
Observational
Shanghai, 200032, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
severity of coronary atherosclerosis
Time frame: two years after angiography
acute myocardial infarction; heart failure; cardiac death; revascularization
Contact information is provided by the study sponsor or research team.
Shanghai Zhongshan Hospital
Other
Acronym: CACA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06541691
Arterial Occlusive Diseases, Arteriosclerosis
Tehran, Tehran Province, Iran
View Trial DetailsNCT06590012
Arterial Occlusive Diseases, Arteriosclerosis
Kazan', Russia
View Trial DetailsNCT07298655
Brain Diseases, Cardiovascular Diseases
Harrow, United Kingdom
View Trial DetailsNCT05838547
Asymptomatic Carotid Artery Stenosis, Brain Diseases
Los Angeles, California, United States
View Trial Details